| | TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
| TRIAL 01-19-3 | Control material NO. | 01-19-3-1 | 01-19-3-2 | 01-19-3-3 | 01-19-3-4 | Non treponemal test | Reactive | Reactive | Reactive | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive |
| | | TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM | TRIAL 02-19-3 | Control material NO. | 02-19-3-1 | 02-19-3-2 | 02-19-3-3 | 02-19-3-4 | HBsAg | NEGATIVE
0.52± 0.14(ECLIA) | NEGATIVE
0.51± 0.14(ECLIA) | NEGATIVE
0.51± 0.13
(ECLIA) | NEGATIVE
0.50±0.13(ECLIA) | antiHBs
(all methods)
(mIU/ml) | POSITIVE
36.71 ± 10.02 | NEGATIVE
2.34± 1.33 | POSITIVE
36.62± 10.51 | NEGATIVE
1.13± 1.18 | antiHBc | POSITIVE | NEGATIVE | POSITIVE | NEGATIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE |
| | | | | TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM |
|
| | TRIAL 01-19-2 | |
| | Control material NO. | 01-19-2-1 | 01-19-2-2 | 01-19-2-3 | 01-19-2-4 | Non treponemal test | Reactive | NS | Non-Reactive | Reactive | Treponemal test | Reactive | Reactive | Non-Reactive | Reactive |
| |
| | | |
| | TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM | |
| | TRIAL 02-19-2 | |
| | Control material NO. | 02-19-2-1 | 02-19-2-2 | 02-19-2-3 | 02-19-2-4 | HBsAg | POSITIVE
188.16± 43.41(ECLIA) | NEGATIVE
0.46± 0.13(ECLIA) | NEGATIVE
0.45± 0.15
(ECLIA) | NEGATIVE
0.43±0.14(ECLIA) | antiHBs
(all methods)
(mIU/ml) | NEGATIVE
2.16 ± 0.75 | POSITIVE
375.83± 22.32 | POSITIVE
311.43± 18.76 | NEGATIVE
2.78± 1.08 | antiHBc | POSITIVE | POSITIVE | NEGATIVE | NEGATIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | POSITIVE | NEGATIVE | NEGATIVE | NEGATIVE |
| |
| | | |
| | | |
| | TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM | |
| | TRIAL 01-19-1 | |
| | Control material NO. | 01-19-1-1 | 01-19-1-2 | 01-19-1-3 | 01-19-1-4 | Non treponemal test | NS | Reactive | Reactive | Reactive | Treponemal test | Reactive | Reactive | Reactive | Reactive |
| |
| | | |
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM |
| | | |
| | TRIAL 02-19-1 | |
| | Control material NO. | 02-19-1-1 | 02-19-1-2 | 02-19-1-3 | 02-19-1-4 | HBsAg | NEGATIVE
0.56± 0.34(ECLIA) | POSITIVE
1626.22± 471.97(ECLIA) | POSITIVE
2169.93± 645.00(ECLIA) | POSITIVE
8395.83± 2637.22(ECLIA) | antiHBs
(all methods)
(mIU/ml) | NEGATIVE
2.28± 1.68 | NEGATIVE
2.56± 2.28 | NEGATIVE
2.67± 2.62 | NEGATIVE
2.58± 2.34 | antiHBc | NEGATIVE | POSITIVE | POSITIVE | POSITIVE | HBeAg | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE | antiHBe | NEGATIVE | NEGATIVE | NEGATIVE | NEGATIVE |
| |
